The Smith Group specializes in identifying biomarkers and developing technologies for the minimally-invasive detection of diseases and illnesses associated with women’s health and mental illness.
Multiomic Biomarker Discovery
In collaboration with clinics, human-derived patient samples are being collected, tested, and analyzed to identify proteomic and metabolic biomarkers related to illness. This work aims to develop a unique diagnostic technology, which is capable of identifying specific molecules associated with women’s health and mental illness.
Photoacoustic Imaging Technologies
Our lab develops photoacoustic and ultrasound imaging technologies to elucidate fundamental knowledge of the behavior of the single cell and neural networks. In addition, we engineer novel system designs for the clinical analysis and early diagnosis of endometrial and ovarian cancers for use at the point of care.